Remove Acquisition Remove Blogging Remove Sales Remove San Diego
article thumbnail

LendingPoint Adds Point-of-Sale Financing with LoanHero Buyout

Xconomy

LendingPoint , an online provider of direct loans to consumers, has acquired LoanHero , the San Diego fintech with technology that enables merchants to extend instant financing to consumers at the point of sale. Financial terms of the buyout were not disclosed in an announcement Thursday. Read more » Reprints | Share:

Sales 68
article thumbnail

Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Xconomy

The San Diego-based company splashed out $52.5 Acadia agreed to pay CerSci shareholders up to $887 million more in payments depending on development, commercialization, and sales milestones, plus royalties. million on the buyout, a cash-and-stock deal—$47.2 Read more » Reprints | Share:

San Diego 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Seismic Acquires Savo Group, Rival in Sales Enablement Software

Xconomy

In the eight years since it was founded, Seismic has become a leader in the market for Web-based software used by corporations and other big customers to manage the online marketing materials created to support sales reps in the field. Financial terms of the deal are being withheld, according to Seismic CEO Doug Winter.

Sales 70
article thumbnail

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Xconomy

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. Morristown, NJ-based Pernix (NASDAQ: PTX ) will cut 60 workers , mostly from its neurology sales staff, the company said today.

Sales 40
article thumbnail

Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More

Xconomy

It’s a lot to pay for a drug that hasn’t lived up to sales expectations but Hantson. This week, Alexion agreed to pay $1.4 billion for Portola Pharmaceuticals, whose main product treats emergency bleeding—not exactly a rare disease. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More

Xconomy

Bristol-Myers Squibb this week completed its acquisition of Celgene, a $74 billion deal that creates a pharmaceutical juggernaut. And all it took was the largest asset sale ever required by federal antitrust regulators.

article thumbnail

Corza Health Emerges Led by Former NuVasive, GreatCall Executives

Xconomy

A Chicago-based private equity firm has tapped the former head of NuVasive and finance chief of GreatCall to start a new healthcare company in San Diego. The company, Corza Health, is headed by Greg Lucier, most recently CEO at NuVasive, and backed by the PE firm, GTCR, with money from its $5.25 billion Fund XII.